Patents by Inventor Oleg Y. Fedoroff

Oleg Y. Fedoroff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040229894
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. 1H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Application
    Filed: February 10, 2004
    Publication date: November 18, 2004
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley
  • Patent number: 6689887
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. 1H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: February 10, 2004
    Assignee: Board of Regents, The University of Texas System
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley
  • Patent number: 6623930
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. 1H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Grant
    Filed: August 27, 2001
    Date of Patent: September 23, 2003
    Assignee: Board of Regents, The University of Texas System
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley
  • Publication number: 20030040525
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. 1H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Application
    Filed: August 27, 2001
    Publication date: February 27, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley
  • Publication number: 20020107258
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. 1H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Application
    Filed: December 5, 2000
    Publication date: August 8, 2002
    Applicant: Board of Regents, The Universty of Texas System
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley
  • Patent number: 6156763
    Abstract: Certain non-nucleoside compounds that will selectively inhibit telomerase by targeting the nucleic add structures, such as G-quadruplexes, that may be associated with human telomeres or telomerase have been identified. Inhibition of human telomerase by two perylenetetracarboxylic acid diimides and a carbocyanine has been demonstrated. .sup.1 H-NMR studies have evidenced the stabilization of a G-quadruplex by the perylenetetracarboxylic acid diimide compounds and provided evidence that these and structurally related compounds inhibit the telomerase enzyme by a mechanism consistent with interaction with G-quadruplex structures.
    Type: Grant
    Filed: February 4, 1999
    Date of Patent: December 5, 2000
    Assignee: Board of Regents, The University of Texas System
    Inventors: Sean M. Kerwin, Oleg Y. Fedoroff, Miguel Salazar, Laurence H. Hurley